Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand
about
New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.HIV-1 and Hepatitis C virus selection bottleneck in Chinese people who inject drugs.Risky Sexual Behavior among Individuals receiving Buprenorphine/Naloxone Opiate Dependency Treatment: HIV Prevention Trials Network (HPTN) 058.Methadone Treatment of Opiate Addiction: A Systematic Review of Comparative Studies.
P2860
Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Hepatotoxicity in a 52-week ra ...... id users in China and Thailand
@ast
Hepatotoxicity in a 52-week ra ...... id users in China and Thailand
@en
Hepatotoxicity in a 52-week ra ...... id users in China and Thailand
@nl
type
label
Hepatotoxicity in a 52-week ra ...... id users in China and Thailand
@ast
Hepatotoxicity in a 52-week ra ...... id users in China and Thailand
@en
Hepatotoxicity in a 52-week ra ...... id users in China and Thailand
@nl
prefLabel
Hepatotoxicity in a 52-week ra ...... id users in China and Thailand
@ast
Hepatotoxicity in a 52-week ra ...... id users in China and Thailand
@en
Hepatotoxicity in a 52-week ra ...... id users in China and Thailand
@nl
P2093
P2860
P1476
Hepatotoxicity in a 52-week ra ...... id users in China and Thailand
@en
P2093
Alicia Young
Apinun Aramrattana
David Burns
David Metzger
Gregory M Lucas
HPTN 058 study group
J Brooks Jackson
Paul Richardson
P2860
P304
P356
10.1016/J.DRUGALCDEP.2014.06.013
P577
2014-06-19T00:00:00Z